Natus Medical Incorporated
NTUS · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $13,177 | -$16,613 | -$15,671 | -$22,935 |
| Dep. & Amort. | $28,091 | $28,115 | $30,722 | $33,863 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $14,161 | $9,566 | $8,352 | $17,051 |
| Change in WC | $2,934 | -$154 | $7,167 | -$27,820 |
| Other Non-Cash | $5,632 | $13,512 | $29,490 | $32,861 |
| Operating Cash Flow | $63,995 | $34,426 | $60,060 | $33,020 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,620 | -$8,609 | -$5,339 | -$8,540 |
| Net Acquisitions | -$1,000 | -$3,997 | $0 | $151 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $2,674 | $0 | $0 | $0 |
| Investing Cash Flow | -$1,946 | -$12,606 | -$5,339 | -$8,389 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | -$10,495 | $0 | -$5,630 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$60,662 | -$10,877 | -$48,532 | -$49,512 |
| Financing Cash Flow | -$60,662 | -$10,877 | -$48,532 | -$49,512 |
| Forex Effect | -$7,874 | $7,842 | $735 | -$7,696 |
| Net Chg. in Cash | -$6,487 | $18,785 | $6,924 | -$32,577 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $82,082 | $63,297 | $56,373 | $88,950 |
| End Cash | $75,595 | $82,082 | $63,297 | $56,373 |
| Free Cash Flow | $60,375 | $25,817 | $54,721 | $24,480 |